APS 2010 Chronic Cancer Pain

APS 2010 Chronic Cancer Pain

Preventing Inappropriate Opioid Use with REMS (Risk Evaluation and Mitigation Strategy)

Appropriate patient selection for opioid use is critical to ensuring patient safety and minimizing the risks associated with opioid use. Healthcare professionals should therefore understand not only their patients’ needs but also the concept of Risk Evaluation and Mitigation Strategy (REMS), which can help prevent inappropriate opioid use.

African Americans, Whites, Differ in Decision-making Regarding Preferences for Cancer Pain Treatment

A pilot study designed to understand how preferences for analgesic treatment for cancer pain vary between African Americans and whites found that each group may employ different heuristics in making decisions, despite having similar levels of education and health literacy, according to data presented at the American Pain Society’s 29th Annual Scientific Meeting.

Novel and Future Directions in Cancer Pain Management

Presence of pain is often the first sign of cancer; approximately 20% to 75% of patients present with pain at the time of diagnosis. . At the 29th Annual Scientific Meeting of the American Pain Society, Christine Miaskowski, RN, PhD, FAAN, of the University of California at San Francisco, San Francisco, Calif., highlighted the importance of evaluating cancer pain etiologies as well as interindividual variability when managing cancer patients with pain.

Coping With Pain Related to Physical and Psychological Functioning

There is growing evidence that the way individuals cope with and appraise disease-related pain (e.g. arthritis pain and cancer) is not only related to their experience of pain but also to their physical and psychological functioning. Presenting at the American Pain Society 29th Annual Scientific Meeting, Francis J. Keefe, PhD, from Duke University Medical Center in Durham, N.C., reviewed the latest research in behavioral and psychosocial factors in pain and pain management.